| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.168 | 4.901 | 9.259 | 13.319 | 14.323 | 16.106 | 4.749 | 5.575 | 8.349 | 6.802 |
| Total Income - EUR | 9.220 | 5.595 | 10.266 | 16.127 | 27.927 | 25.159 | 7.455 | 14.133 | 8.678 | 6.618 |
| Total Expenses - EUR | 6.417 | 12.732 | 7.744 | 15.399 | 22.257 | 21.867 | 15.457 | 13.627 | 6.721 | 8.342 |
| Gross Profit/Loss - EUR | 2.804 | -7.138 | 2.522 | 728 | 5.671 | 3.292 | -8.002 | 506 | 1.957 | -1.725 |
| Net Profit/Loss - EUR | 2.747 | -7.286 | 2.303 | 244 | 5.039 | 3.098 | -8.215 | 174 | 1.565 | -1.725 |
| Employees | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 |
Check the financial reports for the company - Absolut Biolife Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 22.065 | 18.612 | 28.078 | 21.334 | 15.862 | 18.154 | 10.947 | 8.798 | 7.764 | 7.523 |
| Current Assets | 14.390 | 8.849 | 10.547 | 13.806 | 19.419 | 17.941 | 19.717 | 19.815 | 19.971 | 15.515 |
| Inventories | 5.276 | 5.714 | 5.476 | 4.334 | 16.298 | 15.599 | 15.772 | 15.024 | 15.489 | 13.972 |
| Receivables | 8.997 | 2.171 | 1.775 | 2.580 | 1.335 | 1.044 | 762 | 1.241 | 1.201 | 1.288 |
| Cash | 117 | 964 | 3.296 | 6.893 | 1.786 | 1.298 | 3.183 | 3.550 | 3.282 | 256 |
| Shareholders Funds | -11.421 | -18.590 | -15.972 | -15.435 | -10.097 | -6.807 | -6.918 | -6.765 | -5.180 | -6.876 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 47.876 | 46.051 | 54.596 | 50.575 | 45.378 | 42.902 | 37.582 | 35.379 | 32.915 | 29.914 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Absolut Biolife Srl